Balance Sheet
Cash Flow Statement
AcquisitionsAmortizatization of IntangiblesAsset Writedowns and ImpairmentCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Accured ExpensesChange in CashChange in InventoryChange in ReceivablesChange in TaxesDeferred TaxesDepreciation & Amortization (CF)Depreciation and DepletionExchange Rate EffectFree Cash FlowGains from Investment SecuritiesLong-Term Debt RepaymentsNet Cash FlowNet IncomeOther Working Capital ChangesOther financing activitiesSales of Property, Plant and EquipmentShare-based CompensationShares Issued
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Haemonetics (HAE) Gains from Investment Securities (2016 - 2025)

Haemonetics (HAE) has 16 years of Gains from Investment Securities data on record, last reported at -$21.0 million in Q4 2025.

  • For Q4 2025, Gains from Investment Securities fell 2329.02% year-over-year to -$21.0 million; the TTM value through Dec 2025 reached $1.7 million, down 91.3%, while the annual FY2025 figure was $10.2 million, 34.13% down from the prior year.
  • Gains from Investment Securities reached -$21.0 million in Q4 2025 per HAE's latest filing, down from $25.7 million in the prior quarter.
  • Across five years, Gains from Investment Securities topped out at $25.7 million in Q3 2025 and bottomed at -$21.0 million in Q4 2025.
  • Average Gains from Investment Securities over 4 years is $4.9 million, with a median of $4.3 million recorded in 2023.
  • The widest YoY moves for Gains from Investment Securities: up 21158.68% in 2025, down 2329.02% in 2025.
  • A 4-year view of Gains from Investment Securities shows it stood at $19.8 million in 2022, then plummeted by 78.36% to $4.3 million in 2023, then plummeted by 120.18% to -$865000.0 in 2024, then tumbled by 2329.02% to -$21.0 million in 2025.
  • Per Business Quant database, its latest 3 readings for Gains from Investment Securities were -$21.0 million in Q4 2025, $25.7 million in Q3 2025, and $243000.0 in Q2 2025.